Structure and Function of Growth Hormone—A Target for Glucocorticoid Action

Author(s):  
Jack L. Kostyo
2017 ◽  
Vol 37 (7) ◽  
pp. 1696-1707 ◽  
Author(s):  
Kaoru Nashiro ◽  
Jaime Guevara-Aguirre ◽  
Meredith N. Braskie ◽  
George W. Hafzalla ◽  
Rico Velasco ◽  
...  

Endocrine ◽  
2016 ◽  
Vol 54 (3) ◽  
pp. 778-787 ◽  
Author(s):  
Julia D.J. Thomas ◽  
Abhishek Dattani ◽  
Filip Zemrak ◽  
Thomas Burchell ◽  
Scott A. Akker ◽  
...  

1995 ◽  
Vol 79 (5) ◽  
pp. 1571-1577 ◽  
Author(s):  
B. J. Petrof ◽  
S. B. Gottfried ◽  
J. Eby ◽  
J. Lamanca ◽  
S. Levine

The present study tested the hypothesis that growth hormone (GH), an anabolic agent, could prevent the abnormalities of diaphragm structure and function associated with short-term administration of the corticosteroid triamcinolone (TR). During a 10-day period, male rats (n = 33) were assigned to control (CTL), TR (1 mg.kg-1.day-1 im), and TR-GH (2 mg.kg-1.day-1 im) groups. Diaphragm weight was significantly reduced in the TR and TR-GH animals compared with the CTL animals, but there was no difference in the diaphragm-to-body weight ratio. Fiber type (I, IIa, and IIx/b) proportions did not differ among the three groups. However, in TR rats there was a significant reduction in the contribution of type IIx/b fibers to total diaphragm cross-sectional area due to marked atrophy (approximately 42% decrease in mean fiber cross-sectional area). There was no significant reversal of TR-induced type IIx/b fiber atrophy by concomitant GH administration. TR and TR-GH groups both exhibited a left-ward shift of the force-frequency relationship and enhanced in vitro fatigue resistance, whereas maximal specific force was unaltered. We conclude that GH does not prevent corticosteroid-induced effects on the diaphragm under these conditions, possibly as a result of reduced nutritional intake associated with TR administration.


Sign in / Sign up

Export Citation Format

Share Document